recombinant protein development

AgonOx is a cancer immunotherapy company developing TIL (tumor-infiltrating lymphocyte) therapies. It isolates and expands the CD39+CD103+ subset of a patient's tumor-infiltrating lymphocytes, the fraction that is tumor-reactive. Its lead program, AGX-148, is in Phase 1 in solid tumors, with additional cell therapy programs in IND-enabling studies. The company also identifies immunotherapy targets by studying human TIL isolated from tumor types, and designs recombinant proteins, antibodies, or small molecules to block and/or activate immune-specific path

Read more

antibody developmentimmunotherapy target identificationin-vitro human immune assaysmouse tumor modelssmall molecule developmentTIL isolation and expansion

Beacon Analytical Systems, Inc. is a biotechnology development and manufacturing company located in Saco, Maine, USA, established in 1996. It specializes in the development and manufacture of ELISA immunoassay lab testing kits and components, from bulk to finished goods, for environmental, agriculture, and food safety markets. Its QC laboratory is accredited to ISO/IEC 17025:2017 by A2LA.

Read more

calibrator solution preparationcontract method developmentELISA immunoassay developmenthapten design and synthesislabelingpackagingpolyclonal antibody production and purificationproduct assemblysolid phase coatingvialing